We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

78 hedge funds and large institutions have $92.8M invested in Ampio Pharmaceuticals Inc. in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

32% more funds holding

Funds holding: 5978 (+19)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less capital invested

Capital invested by funds: $97.6M → $92.8M (-$4.86M)

61% less call options, than puts

Call options by funds: $1.39M | Put options by funds: $3.56M

Holders
78
Holders Change
+19
Holders Change %
+32.2%
% of All Funds
2.25%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
23
Increased
26
Reduced
13
Closed
4
Calls
$1.39M
Puts
$3.56M
Net Calls
-$2.18M
Net Calls Change
-$898K
Name Holding Trade Value Shares
Change
Change in
Stake
GIM
26
Guild Investment Management
California
$502K -$2.37K -1 -0.4%
UOC
27
UBS O'Connor
Illinois
$476K +$591K +250 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$447K +$113K +48 +26%
Citadel Advisors
29
Citadel Advisors
Florida
$430K +$534K +226 New
Deutsche Bank
30
Deutsche Bank
Germany
$418K +$445K +188 +588%
Millennium Management
31
Millennium Management
New York
$386K +$480K +203 New
AQR Capital Management
32
AQR Capital Management
Connecticut
$357K +$442K +187 New
CP
33
Camelot Portfolios
Ohio
$349K +$7.09K +3 +2%
GIA
34
GHP Investment Advisors
Colorado
$318K
AIG
35
American International Group
New York
$288K +$35.5K +15 +11%
TA
36
Teachers Advisors
New York
$282K
Charles Schwab
37
Charles Schwab
California
$263K
SM
38
Sabby Management
Florida
$260K +$144K +61 +80%
Goldman Sachs
39
Goldman Sachs
New York
$237K -$21.3K -9 -7%
AllianceBernstein
40
AllianceBernstein
Tennessee
$226K +$2.37K +1 +0.8%
PCM
41
Piermont Capital Management
Missouri
$203K +$253K +107 New
HCM
42
Highbridge Capital Management
New York
$202K +$251K +106 New
ProShare Advisors
43
ProShare Advisors
Maryland
$200K +$248K +105 New
GMCM
44
Gruber & McBaine Capital Management
California
$191K +$236K +100 New
BA
45
BlackRock Advisors
Delaware
$185K +$61.5K +26 +37%
PPA
46
Parametric Portfolio Associates
Washington
$168K
NFA
47
Nationwide Fund Advisors
Ohio
$168K +$21.3K +9 +11%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$157K
GC
49
Guggenheim Capital
Illinois
$156K +$49.7K +21 +34%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$146K -$9.46K -4 -5%

AMPE Hedge Fund Activity: Q1 2014 in Review

78 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2014, worth a combined $92.8M — down 5% from $97.6M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AMPE positions and 4 closed out — a net gain of 19 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was DAFNA Capital Management, adding an estimated $9.46M. The largest seller was Noven Financial Group, cutting an estimated $27.9M.

  • 78 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2014, up from 59 in Q4 2013.
  • Funds reported $92.8M of Ampio Pharmaceuticals Inc. stock for Q1 2014, down 5% quarter-over-quarter.
  • 23 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2014 and 4 closed out, a net change of +19 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2014 was DAFNA Capital Management, an estimated $9.46M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2014 was Noven Financial Group, an estimated $27.9M sold.

Based on aggregated 13F filings for Q1 2014.